Last C$134.45 CAD
Change Today +0.80 / 0.60%
Volume 1.5M
VRX On Other Exchanges
Symbol
Exchange
Toronto
New York
Frankfurt
As of 4:03 PM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Howard Bradley Schiller

Chief Financial Officer, Principal Accounting Officer, Executive Vice President and Director, Valeant Pharmaceuticals International, Inc.
AgeTotal Calculated CompensationThis person is connected to 145 board members in 5 different organizations across 8 different industries.

See Board Relationships
51$6,715,711
As of Fiscal Year 2012

Background*

Mr. Howard Bradley Schiller has been the Chief Financial Officer and Executive Vice President of Valeant Pharmaceuticals International, Inc. since December 2011 and serves as its Principal Accounting Officer. Mr. Schiller serves as a Chief Financial Officer and an Executive Vice President at Valeant Pharmaceuticals North America LLC. He has been Treasurer of Solta Medical, Inc. since January 23, 2014 and Obagi Medical Products, Inc. since April 25, 2013. He has been ...

Read Full Background

Corporate Headquarters*

2150 St. Elzéar boulevard West
Laval, Quebec H7L 4A8

Canada

Phone: 514-744-6792
Fax: 514-744-6272

Board Members Memberships*

Trustee
2012-Present
Chief Financial Officer, Executive Vice President, Treasurer, and Director
2012-Present
Chief Financial Officer, Principal Accounting Officer, Executive Vice President and Director
2013-Present
Treasurer and Director
2014-Present
Treasurer and Director

Education*

JD
University of Chicago Law School
BS
University of Pennsylvania - The Wharton School

Other Affiliations*

Annual Compensation*

Salary$1,000,000
Total Annual Compensation$1,000,000

Stock Options*

Restricted Stock Awards$4,306,375
All Other Compensation$46,586
Exercisable Options50,000
Exercisable Options Value$678,000
Unexercisable Options150,000
Unexercisable Options Value$2,034,000
Total Value of Options$2,712,000
Total Number of Options200,000

Total Compensation*

Total Annual Cash Compensation$2,409,336
Total Short Term Compensation$1,000,000
Other Long Term Compensation$4,352,961
Total Calculated Compensation$6,715,711
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VRX:CN C$134.45 CAD +0.80

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Paul M. Bisaro Chairman, Chief Executive Officer and President
Actavis plc
$2.6M
David E. I. Pyott Chairman and Chief Executive Officer
Allergan Inc.
$1.4M
Brenton L. Saunders J.D.Chief Executive Officer, President, Director, Chairman of Compensation Committee and Member of Compliance Committee
Forest Laboratories Inc.
--
Heather Bresch Chief Executive Officer, Director and Member of Science & Technology Committee
Mylan, Inc.
$1.1M
Flemming Ornskov M.D., MBA, MPHChief Executive Officer and Director
Shire plc
$2.7M
Compensation as of Fiscal Year 2013.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VALEANT PHARMACEUTICALS INTE, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.